Acute myeloid leukaemia

• FILO-AML-01-MIVONU A single arm phase II study investigating the efficacy and safety of the addition of ivosidenib to oral azacitidine (Onur … Pending
  2025-521322-14-00 4 "Patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 "
• A Phase 1 Study of AUTX-703 in Participants with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes Pending
  2025-521394-13-00 1 "Relapsed/refractory Acute Myeloid Leukemia or relapsed/refra"
• Administration of Gilteritinib to eliminate MRD in patients with AML and FLT3-ITD mutation. Pending
  2025-521875-30-00 4
• A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia … Pending
  2025-523238-17-00 4 "Acute myeloid leukemia"
• Studies testing Ziftomenib together with standard treatments in adults with newly diagnosed acute myeloid leukemia (AML) that has specific g … Recruiting
  2025-521314-25-00 5 2026-03-19 "NPM1-m and KMT2A-r Acute Myeloid Leukemia"
• RVU120 Rollover Study Recruiting
  2025-521673-14-00 4 2025-12-03 "Relapsed / Refractory Metastatic or Advanced Solid Tumors"
• A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting
  2025-522979-29-00 5 2026-04-30 "Acute myeloid leukemia"
• A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, b … Recruiting
  2024-519498-20-00 9 2025-05-13 "Acute Myeloid Leukaemia (AML)/higher-risk Myelodysplastic Sy"
• VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided phase 2 study Recruiting
  2024-516116-19-00 4 2025-01-01 "Acute Myeloid Leukaemia"
• MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leu … Recruiting
  2023-503394-37-00 5 2024-10-23 "Acute Myeloid Leucaemia"
• PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting
  2023-510415-19-00 4 2024-08-28 "Acute Myeloid Leukemia"
• A study of the safety and efficacy of MB-dNPM-1-TCR.1 in patients with relapsed or refractory AML. Recruiting
  2023-505806-41-00 7 2024-08-01 "Acute myeloid leukemia"
• A Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of RV … Recruiting
  2023-505911-19-00 4 2024-01-05 "Acute Myeloid Leukemia"
• A study of MP0533 in patients with blood cancer. Recruiting
  2023-505259-39-00 7 2023-03-02 "Acute Myeloid Leukemia (AML)"
• A Safety Study of PF-08046040/SEA-CD70 in Patients with Myeloid Malignancies Recruiting
  2023-506945-42-00 1 2022-01-21
• Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment Recruiting
  2024-516291-16-00 3 2021-10-26 "Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS)"
• Study to identify the most appropriate therapy for patients with Acute Myeloid Leukemia carrying FLT3 mutation, using the PBC biomarker to c … Recruiting
  2023-505901-17-00 5 2020-04-24 "Acute Myeloid Leukemia (LMA) with FLT3 mutation"
• A study evaluating the safety and efficacy of ponatinib for the treatment of recurrent or refractory leukemias or solid tumors in children Recruiting
  2023-509699-41-00 9 2019-11-22 "Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumo"
• FILOAML-RR-01-OGILAR: Open-label, phase 2 study investigating the efficacy and safety of the addition of oral-azacitidine to salvage treatme … Recruitment ended
  2022-501372-25-00 4 2024-01-10 "Patients aged 18 years and older with relapsed or refractory"
• A Study of the Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination with Venetoclax in AML Recruitment ended
  2024-516294-78-00 4 2022-06-17 "Acute Myeloid Leukemia (AML)"
• Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 Recruitment ended
  2024-516293-29-01 4 2022-03-17 "Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS)"
• Study aimed at evaluating the efficacy of the combination of the two drugs, Venetoclax and Azacitidine, on the treatment of patients sufferi … Recruitment ended
  2023-510432-36-00 4 2022-03-01 "Acute Myeloid Leukemia with NPM1 mutation"
• Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment Recruitment ended
  2024-516292-33-00 3 2021-10-22 "Myelodysplastic syndrome (MDS)"
• Study to determine safety, efficacy and tolerability of Venetoclax in combination with Fludarabine, Citarabine and Idarubicin to achieve "th … Recruitment ended
  2023-510517-26-00 9 2018-10-26 "Acute Myeloid Leukemia"

Showing 1–24 of 37 trials